The proliferative capacity of SETD2-knockdown PTECs was higher than that of SETD2 wild-type PTECs, indicating that SETD2 inactivation enables PTECs to facilitate a malignant transformation toward ccRCC (67). Here, SETD2 is linked to nonpapillary renal cell carcinoma.